Key Updates
Rigetti Computing has declined 15.13% to $16.18 since the May 12th report, accelerating a broader correction that has now erased the entire 13-session rally. The stock has fallen 26.93% year-to-date and 37.05% over six months, with intensifying pressure over the past month (-18.30%) and week (-21.09%). The latest decline follows Quantinuum's formal SEC registration statement filing for its IPO, which provides detailed disclosure of the competitive threat: Quantinuum generated $5.2 million in Q1 2025 revenue despite a $136.6 million net loss, demonstrating operational scale that dwarfs Rigetti's capabilities. The quantum computing sector faces mounting skepticism as industry leaders collectively burn approximately $500 million in operating cash while awaiting a commercial breakthrough comparable to ChatGPT's impact on AI.
Current Trend
Rigetti has entered a severe downtrend, declining 26.93% year-to-date and breaking below all previous support levels established during the brief May rally. The 21.09% five-day decline represents capitulation selling, with the stock surrendering the $19-20 support zone that held during the previous correction. Trading at $16.18, Rigetti now approaches the psychologically critical $15 level, with no meaningful technical support visible until the $12-13 range from earlier 2026. The 37.05% six-month decline reflects sustained institutional distribution, while the accelerating pace of losses (9.33% single-day drop) indicates deteriorating sentiment. Volume patterns suggest institutional investors are reassessing quantum computing exposure ahead of Quantinuum's IPO, which threatens to absorb significant capital from the limited pool of quantum-focused investors.
Investment Thesis
The investment thesis for Rigetti centers on capturing early-stage exposure to quantum computing's commercialization, positioning ahead of potential breakthrough applications in drug discovery, cryptography, and optimization problems. However, this thesis faces critical challenges: government contracts account for over 60% of revenue at most quantum firms, limiting commercial scalability and creating dependency on public sector spending. The sector's $7.2 billion in capital raised over five years has yet to produce sustainable business models, with Quantinuum's deteriorating metrics (revenue declining from $19.1M to $5.2M year-over-year while losses quadrupled) demonstrating that even well-capitalized competitors struggle with commercialization. Rigetti's SPAC-driven public listing, contrasted with Quantinuum's traditional IPO approach that "legitimizes" the sector, raises questions about financial quality and long-term viability.
Thesis Status
The investment thesis has materially weakened since the May 12th report. Quantinuum's IPO filing reveals stark competitive disadvantages: the company operates a commercially deployed quantum computing platform with engagements across pharmaceuticals, materials science, financial services, and government sectors, supported by Honeywell's resources and a $10 billion valuation. Rigetti's inability to maintain the May rally, despite positive sector momentum, suggests the market views it as a lower-quality asset within quantum computing. The sector's $500 million collective cash burn and difficulty securing traditional financing disproportionately impacts smaller players like Rigetti, which lack the balance sheet strength of Honeywell-backed competitors. The thesis remains speculative, dependent on Rigetti achieving technical breakthroughs or commercial traction before capital markets close to cash-burning quantum ventures. Current price action indicates investors are rotating toward quality, favoring well-funded competitors over speculative pure-plays.
Key Drivers
Quantinuum's SEC registration statement filing represents the primary near-term driver, introducing a formidable competitor with superior capitalization, commercial deployment, and Fortune 500 backing. The IPO, led by J.P. Morgan and Morgan Stanley with listing planned on Nasdaq Global Select Market under "QNT," will provide Quantinuum additional capital for market share expansion while establishing valuation benchmarks that may pressure smaller competitors. Quantinuum's traditional IPO approach, described by Wedbush as signaling a "mature, well-funded, higher-quality asset," contrasts unfavorably with Rigetti's SPAC route, potentially triggering investor reassessment of quality tiers within quantum computing. Sector-wide challenges including qubit fragility, error-proneness, and the $500 million collective operating cash burn create existential pressure on companies lacking clear paths to profitability. The broader quantum computing rally's reversal from October 2024 peaks suggests speculative capital is exiting the sector, with D-Wave and Rigetti showing significant volatility as investors demand evidence of commercial viability beyond government contracts.
Technical Analysis
Rigetti has broken critical support at $19.07 (May 12th level) and $17.50, now trading at $16.18 with accelerating downward momentum. The 9.33% single-day decline on May 18th represents the sharpest drop since the correction began, suggesting panic selling rather than orderly distribution. The stock has violated all moving average support levels, with the 26.93% year-to-date decline establishing a clear downtrend channel. Next support lies at the psychological $15.00 level, followed by the $12-13 range representing earlier 2026 lows. Resistance has formed at $17.50-19.00, previously support, with the 50-day moving average likely providing additional overhead resistance. Volume patterns during the decline suggest institutional liquidation, with the 21.09% five-day drop indicating sustained selling pressure rather than temporary profit-taking. The technical structure offers no bullish signals, with all momentum indicators pointing lower and no signs of capitulation or reversal formation.
Bull Case
- Quantum computing's potential breakthrough in drug discovery and molecular modeling could meaningfully improve pharmaceutical industry economics, where R&D costs have doubled over the past decade, creating substantial addressable market opportunity for early-stage technology providers capable of delivering commercial solutions.
- National security concerns and geopolitical competition in quantum computing may sustain government contract revenue, providing baseline cash flow while commercial applications mature, particularly as quantum computing represents strategic technology with defense and intelligence applications.
- IBM, Google, and startups have raised $7.2 billion over five years, demonstrating continued investor appetite for quantum computing exposure and suggesting capital availability for companies that demonstrate technical progress or commercial traction.
- Quantinuum's IPO filing validates the quantum computing sector, potentially attracting new institutional capital to the space and lifting valuations for all public quantum computing companies as the sector gains mainstream investment recognition.
- The 37.05% six-month decline and 26.93% year-to-date loss have reset valuation expectations, potentially creating entry opportunities for investors with long-term horizons willing to accept commercialization risk in exchange for exposure to transformative technology with applications across multiple high-value industries.
Bear Case
- Quantinuum reported a net loss of $136.6 million on revenue of $5.2 million in Q1 2025, a significant deterioration from $30.5 million loss on $19.1 million revenue year-over-year, demonstrating that even well-capitalized competitors with commercial deployments struggle with path to profitability, raising existential questions about smaller players like Rigetti.
- Four major quantum firms are burning approximately $500 million in combined operating cash in their most recent financial years, with government contracts accounting for over 60% of revenue, making traditional financing difficult and forcing companies toward SPAC mergers that carry high shareholder redemption risks and valuation pressure.
- Quantinuum's traditional IPO approach "legitimizes" the quantum sector and signals it is a "mature, well-funded, higher-quality asset", implicitly positioning SPAC-listed competitors like Rigetti as lower-quality speculative ventures and potentially triggering investor rotation toward better-capitalized players with Fortune 500 backing.
- Quantum computing faces significant technical challenges including qubit fragility and error-proneness, with current commercial applications remaining limited despite years of development and billions in investment, suggesting the "ChatGPT moment" breakthrough may be years away while cash burn continues.
- Quantinuum operates commercially deployed quantum computing platform with active engagements across pharmaceuticals, material science, financial services, and government sectors, with facilities across multiple countries and integration with Nvidia's AI supercomputing technology, creating competitive moat that smaller players like Rigetti cannot easily replicate without substantial capital infusion.